News
08-17-2025, 07:31 PM
Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option.
More... (https://www.news-medical.net/news/20250817/Plasma-proteomics-study-unlocks-predictive-biomarkers-for-TNBC-immunotherapy.aspx)
More... (https://www.news-medical.net/news/20250817/Plasma-proteomics-study-unlocks-predictive-biomarkers-for-TNBC-immunotherapy.aspx)